Cough & Lung Acoustic Endpoints for Clinical Trials
The RESP® Biosensor
FDA 510(k) Class II | CE Mark | HIPAA Compliant
RESP® Biosensor Overview
The RESP® Biosensor is a next generation digital health technology developed to collect greater respiratory insights in clinical trials and research studies.
- Patient-Friendly: Wireless, discreet form factor that respects patient comfort in daily life
- Multi-Parameter: Comprehensive respiratory and physiological measurements
- Validated Reporting: Automated or manual (human) analysis of cough and lung sounds
Measures
A robust combination of multi-modal data alongside patient reported outcomes (PROs)
-
-
-
-
- Cough Frequency (24-hour)
- Cough Sound Intensity & Bouts
- Wheeze, Rhonchi, Crackles
- Breathing Patterns*
- Respiratory Rate*
- Heart Rate & Heart Rate Variability*
- Orientation (e.g. Supine or Upright)*
- Sleep/Wake*
- Activity Levels*
-
-
-
*Measurement not FDA cleared but may be collected in clinical trials
Metrics-at-a-Glance
1.5M
Lung Sounds Captured
50M
Breaths Captured
5
Continents
34
Countries
36
Languages
245
Sites
Why Measure Cough & Lung Sounds in Your Study?
From primary, exploratory endpoints to sub-studies, RESP® can add value to your clinical program by:
- Increasing evidence and insight into how patients feel and function
- Reducing reliance on PROs to demonstrate treatment effectiveness with another objective lens
- Differentiating your asset in an increasingly competitive market
- Uncovering signals that may point to new or expanded indications
Digital Endpoints for Multiple Indications
Unlock insight across therapeutic areas to complement patient-reported outcomes and strengthen evidence
| Cough | Wheeze | Crackles | Rhonchi | Respiratory Rate* | Heart Rate* | Activity* | |
| Chronic Cough | |||||||
| Pulmonary Fibrosis | |||||||
| Bronchiectasis | |||||||
| COPD | |||||||
| Asthma | |||||||
| Infectious Diseases | |||||||
| Lung Cancer | |||||||
| Congestive Heart Failure |
- Chronic Cough
- IPF
- Bronchitis
- COPD
- Asthma
- RSV
- Covid-19
- Heart Failure
*Measurement not FDA cleared but may be collected in clinical trials
Features & Specifications
-
- Wireless and discreet
- Passive and continuous
- Lightweight (100g)
- Data transfer to cloud
- 24+ hour battery life
- Water resistant
- Adhered to chest via 3M Tegaderm dressing
- Patient-privacy preserving (HIPAA compliant)
- Flexible reporting including automated or human analysis of cough and lung sounds
- Verifications: FDA 510(k) Class II and CE Mark
Publications
Cough Detection Performance of the CoughCheck Algorithm in Subjects with Subacute Cough
Poster Presentation, American Thoracic Society, 2025
Poster Presentation, American Cough Conference, 2023
Talk to our Team
Explore using the RESP® Biosensor in your next study





